Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Tauschmann M, Thabit H, Bally L, et al.
The Lancet. Pub. online October 3, 2018
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Hernandez AF, Green JB, Janmohamed S, et al.
The Lancet. Pub. online October 2, 2018
Leggi
Glucose lowering and the kidney: are all drug classes equal?
Wong MG, Jardine M, Perkovic V
Lancet Diabetes Endocrinol. Pub. online October 3, 2018
Leggi
Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
Muskiet MHA, Tonneijck L, Huang Y, et al.
Lancet Diabetes Endocrinol. Pub. online October 3, 2018
Leggi
Comparison of Medical Care Utilization and Costs Among Patients with Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia
Nichols GA, Philip S, Reynolds K, et al.
Am J Cardiol 2018; 122(7):1128-32
Leggi
Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events with Systolic Blood Pressure <120 mm Hg Versus 135-139 mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup
Plante TB, Juraschek SP, Miller III ER, et al.
Am J Cardiol 2018; 122(7):1185-90
Leggi
Dangers of hypoglycemia in cardiac patients with diabetes.time to switch to safer, newer drugs
Deedwania P
Journal of the American College of Cardiology. 2018;72(15):1787-9
Leggi
James Lind Alliance research priorities: what role do carbohydrates, fats and proteins have in the management of type 2 diabetes, and are there risks and benefits associated with particular approaches?
Dyson P, McArdle P, Mellor D, Guess N
Diabetic Medicine. Pub online 27 September 2018.
Leggi
Doctor Referral of Overweight People to Low Energy Total diet replacement treatment (DROPLET): pragmatic randomised controlled trial
Astbury NM, Aveyard P, Nickless A, et al.
BMJ 2018;362:k3760
Leggi
Immunological biomarkers for the development and progression of type 1 diabetes
Mathieu C, Lahesmaa R, Bonifacio E, et al.
Diabetologia. 2018;61(11):2252-58
Leggi